Back
ESC Professional Premium Access

Amiodarone induced thyroid dysfunction.

Session: Clinical pharmacology
Topic: Antiarrhythmic Pharmacotherapy
Speaker: Doctor P. Gudjonsson (Reykjavik, IS)
Event: ESC Congress 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Pall Gudjonsson

Landspitali University Hospital, Reykjavik (Iceland)
0 follower

7 more presentations in this session

Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study

Speaker: Mr S. Nielsen (Hellerup, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats

Speaker: Doctor J. Wikstrom (SE)

Access
Abstract
Slides
Video
Like
Thumbnail

RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry

Speaker: Doctor C. Basile (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Xanthine oxidase inhibitors withdrawal syndrome

Speaker: Doctor M. Kuwabara (Shimotsuke, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study.

Speaker: Doctor B. Al-Abbasi (Roskilde, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Clinical pharmacology

Speakers: Doctor P. Gudjonsson, Mr S. Nielsen, Doctor J. Wikstrom, Doctor C. Basile, Doctor M. Kuwabara...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources